While genetic testing for the FBN1 gene, as suggested by the Ghent criteria, improves the likelihood of diagnosing MFS, it is insufficient for ruling out other Marfan-like connective tissue disorders. The gene discussed is FBN1; the disease is Marfan syndrome.